A Comprehensive Review of Computer-Aided Models for Breast Cancer Diagnosis Using Histopathology Images.

Bioengineering (Basel)

Department of Biomedical Engineering, The University of Akron, Akron, OH 44325, USA.

Published: November 2023

Breast cancer is the second most common cancer in women who are mainly middle-aged and older. The American Cancer Society reported that the average risk of developing breast cancer sometime in their life is about 13%, and this incident rate has increased by 0.5% per year in recent years. A biopsy is done when screening tests and imaging results show suspicious breast changes. Advancements in computer-aided system capabilities and performance have fueled research using histopathology images in cancer diagnosis. Advances in machine learning and deep neural networks have tremendously increased the number of studies developing computerized detection and classification models. The dataset-dependent nature and trial-and-error approach of the deep networks' performance produced varying results in the literature. This work comprehensively reviews the studies published between 2010 and 2022 regarding commonly used public-domain datasets and methodologies used in preprocessing, segmentation, feature engineering, machine-learning approaches, classifiers, and performance metrics.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669627PMC
http://dx.doi.org/10.3390/bioengineering10111289DOI Listing

Publication Analysis

Top Keywords

breast cancer
12
cancer diagnosis
8
histopathology images
8
cancer
6
comprehensive review
4
review computer-aided
4
computer-aided models
4
breast
4
models breast
4
diagnosis histopathology
4

Similar Publications

Study Objectives: Cancer-related fatigue is one of the most common symptoms in cancer survivors. Cognitive behavioural therapy for insomnia (CBT-I) can improve fatigue, but mechanisms are unclear. This secondary analysis of a randomized controlled trial evaluated whether CBT-I led to a significant improvement in fatigue, accounting for change in comorbid symptoms of insomnia, perceived cognitive impairment (PCI), anxiety, and depression.

View Article and Find Full Text PDF

The efficacy of photodynamic treatment (PDT) against deep-seated tumor is hindered by low penetration depth of light as well as hypoxic conditions which prevails in tumor. To overcome this limitation, Near-infrared (NIR) absorbing photosensitizers have been investigated actively. In the present study we evaluated the PDT efficacy of an NIR absorbing chlorophyll derivative 'Cycloimide Purpurin-18 (CIPp-18)' in Human Breast carcinoma (MCF-7) and cervical adenocarcinoma (Hela) cells under normoxic and hypoxic conditions.

View Article and Find Full Text PDF

Purpose Of Review: Male breast cancer (MBC) is a rare entity which often arises in elderly people. Aim of this review is to evaluate the principal issues related to MBC in elderly, because the therapeutic management of disease is not only related to the biological behavior of the tumor, but also to the comorbidities and frailty of older population. A scoping literature review was performed on Pubmed and Cochrane Database using the following keywords: therapeutic management/ male/ breast cancer/ elderly patients.

View Article and Find Full Text PDF

Efficacy and safety of KN026 and docetaxel for HER2-positive breast cancer: a phase II clinical trial.

Cancer Commun (Lond)

January 2025

Department of Medical Oncology, Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, P. R. China.

Background: The standard first-line treatment for human epidermal growth factor receptor 2 (HER2)-positive recurrent/metastatic breast cancer currently includes pertuzumab plus trastuzumab and docetaxel. This study aimed to evaluate the effectiveness of KN026, an anti-HER2 bispecific antibody, plus docetaxel in first-line treatment of HER2-positive recurrent/metastatic breast cancer.

Methods: This open-label, single-arm, phase II study enrolled patients with HER2-positive recurrent/metastatic breast cancer in 19 centers across China from December 30, 2019 to May 27, 2021.

View Article and Find Full Text PDF

Background: Population-level mammography screening for early detection of breast cancer is a secondary prevention measure well-embedded in developed countries, and the implications for women's health are widely researched. From a public health perspective, efforts have focused on why mammography screening rates remain below the 70% screening rate required for effective population-level screening. From a sociological perspective, debates centre on whether 'informed choice' regarding screening exists for all women and the overemphasis on screening benefits, at the cost of not highlighting the potential harms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!